Sagimet Biosciences
SGMT
SGMT
88 hedge funds and large institutions have $69.8M invested in Sagimet Biosciences in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.73% less ownership
Funds ownership: 46.43% → 41.71% (-4.7%)
18% less capital invested
Capital invested by funds: $85.2M → $69.8M (-$15.5M)
Holders
88
Holding in Top 10
1
Calls
$1.72M
Puts
$1.14M
Top Buyers
| 1 | +$1.58M | |
| 2 | +$1.53M | |
| 3 | +$1.04M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$753K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$514K |
Top Sellers
| 1 | -$5.07M | |
| 2 | -$4.29M | |
| 3 | -$1.56M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$916K |
| 5 |
Jane Street
New York
|
-$419K |
